2016 - 2018 Development of vaccine therapy for pulmonary arterial hypertension
Papers (56)：
Toru Sato, Yoshito Ogihara, Kakuya Kitagawa, Toru Ogura, Norikazu Yamada, Kaoru Dohi. Diagnostic performance of fluoroscopic video analysis for pulmonary embolism: a prospective observational study. The international journal of cardiovascular imaging. 2024
Ryuki Chatani, Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, Michihisa Umetsu, Yuji Nishimoto, Takuma Takada, Yoshito Ogihara, Tatsuya Nishikawa, Nobutaka Ikeda, et al. Edoxaban for 12 Versus 3 Months in Cancer-associated Isolated Distal Deep Vein Thrombosis According to Different Doses: Insights from the ONCO DVT study. European heart journal. Cardiovascular pharmacotherapy. 2024
Daisuke Sueta, Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, Michihisa Umetsu, Yuji Nishimoto, Takuma Takada, Yoshito Ogihara, Tatsuya Nishikawa, Nobutaka Ikeda, et al. The impact of renal function on clinical outcomes of patients with cancer-associated isolated distal deep vein thrombosis: Insights from the ONCO DVT study. Thrombosis research. 2024. 235. 107-115
Ryuki Chatani, Yugo Yamashita, Takeshi Morimoto, Kazunori Mushiake, Kazushige Kadota, Kazuhisa Kaneda, Yuji Nishimoto, Nobutaka Ikeda, Yohei Kobayashi, Satoshi Ikeda, et al. Cancer-associated venous thromboembolism in the direct oral anticoagulants era: Insight from the COMMAND VTE Registry-2. Thrombosis research. 2024. 234. 86-93
Masaki Ishiyama, Naoki Fujimoto, Shusuke Fukuoka, Taku Omori, Keishi Moriwaki, Yoshito Ogihara, Shiro Nakamori, Tairo Kurita, Ryuji Okamoto, Kaoru Dohi. Effects of a Rho-Kinase Inhibitor in Patients With Pulmonary Hypertension Due to Left Heart Disease. JACC. Heart failure. 2024. 12. 2. 409-411
